In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany

International Journal of Antimicrobial Agents

Volumn 33, Issue 3, 2009, Pages 272-275

  Alba, Veronica ^a   Urban, Edit ^b   Angeles Dominguez, M ^c   Nagy, Elisabeth ^b   Nord, Carl Erik ^d   Palacín, Celia ^e   Vila, Jordi ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF SZEGED   (Hungary)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

Fluoroquinolones; Gram positive bacteria; Nadifloxacin

Indexed keywords

AGAR; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; NADIFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DILUTION; DRUG SENSITIVITY; DRUG USE; GERMANY; GRAM POSITIVE BACTERIUM; HUNGARY; IN VITRO STUDY; MICROORGANISM; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SPAIN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; QUINOLIZINES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 60249097712     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.024     Document Type: Article

References (15)

1. Vila J. Fluoroquinolone resistance. In: White D.G., Alekshun M.N., and McDermott P.F. (Eds). Frontiers in antimicrobial resistance (2005), ASM Press, Washington, DC 41-52
2. Ishikawa H., Tabusa F., and Miyamoto H. Studies on antibacterial agents. I. Synthesis of substituted 6,7-dihydro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acids. Chem Pharm Bull (Tokyo) 37 (1989) 2103-2108
3. Kawabata S., Masada H., Wakebe H., Ohmori K., and Tamaoka H. Bacteriological evaluation of OPC-7251, a new pyridine carboxylic acid antimicrobial agent. Chemotherapy 37 (1989) 1179-1183
4. Muto N., Mitoh Y., and Yamamoto I. Development of a sensitive enzyme immunoassay for OPC-7251, a novel antimicrobial agent for percutaneous application. J Immunoassay 11 (1990) 1-16
5. Vogt K., Hermann J., Blume U., Gollnick H., Hahn H., Hanstein U.F., et al. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Eur J Clin Microbiol Infect Dis 11 (1992) 943-945
6. Vogt K., Hahn H., Hermann J., Hanstein U.F., Blume U., Gollnick H., et al. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris. Drugs 49 Suppl. 2 (1995) 266-268
7. Nishijima S., Namura S., Akamatsu H., Kawai S., Asada Y., Kawabata S., et al. Activity of eight fluoroquinolones against both methicillin-susceptible and -resistant Staphylococcus aureus isolated from skin infections. J Dermatol 22 (1995) 153-155
8. Nenoff P., Haustein U.F., and Hittel N. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. Chemotherapy 50 (2004) 196-201
9. Nishijima S., Nakagawa M., Tsuboi N., Akamatsu H., Horio T., Fujita M., et al. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones. J Int Med Res 24 (1996) 12-16
10. Nishijima S., Namura S., Kawai S., Akamatsu H., Asada Y., and Kawabata S. Sensitivity of Staphylococcus aureus and Streptococcus pyogenes isolated from skin infections in 1992 to antimicrobial agents. J Dermatol 21 (1994) 233-238
11. Perry A.L., and Lambert P.A. Propionibacterium acnes. Lett Appl Microbiol 42 (2006) 185-188
12. Sierra J.M., Marco F., Ruiz J., Jiménez de Anta M.T., and Vila J. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin Microbiol Infect 8 (2002) 781-790
13. Oizumi N., Kawabata S., Hirao M., Watanabe K., Okuno S., Fujiwara T., et al. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus. J Infect Chemother 7 (2001) 191-194
14. Nishijima S., Kurokawan I., Katoh N., and Watanabe K. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol 27 (2000) 318-323
15. Høiby N., and Johansen H.K. Ciprofloxacin in sweat and antibiotic resistance. The Copenhagen Study Group on Antibiotics in Sweat. Lancet 346 (1995) 1235